FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21714011000001107: Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73116601000001116 Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73116701000001114 Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Is a Ursodeoxycholic acid 500mg tablets true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Is a Ursofalk true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has AMP True Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start